Translational Development Acquisition Corp. (TDAC US)
TDAC US$10.85
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Share price activity
- Last (Price)
- 10.85
- Change
- ▲ 0.04 (0.37)
- Bid / Ask
- 10.81 - 11.79
- Volume
- 1,426
- Turnover
- 14,572
- Open
- 10.85
- Day Range
- 10.85 - 10.85
- VWAP
- 10.85
- Prev Close
- 10.81
- Last Trade
- 28/10 1:20pm
Key information
- Sector
- Financial Services
- Shares Issued
- 17,250,000
- NTA/Share
- 7.99
- Last Dividend
- —
- Dividend Ex Date
- —
- Dividend Pay Date
- —
Current (USD) · FY2025
- Revenue
- 0.00
- EBITDA
- 6.36
- Profit
- 6.36
- Earnings Per Share (EPS)
- 0.29
- Dividend Per Share (DPS)
- —
- Yield %
- 0.00
- Market Cap
- 209.50
- Price to Earnings Ratio (P/E)
- 41.73
Estimates (AUD)
No consensus estimates are available for this company.
Quantitative rating
Overvalued
- Economic Moat
- Narrow
- Financial Health
- Strong
- Uncertainty
- High
Morningstar Quantitative Rating as of 23 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Five-star price 6.25 Fair value 9.55 One-star price 14.61
Morningstar Quantitative Rating as of 23 OCT 2026.
Quantitative valuation
- Fair Value
- 9.55
- Price / Fair Value
- 1.13
- Valuation
- Overvalued
- Uncertainty
- High
Morningstar Quantitative Rating as of 23 OCT 2026. The slider runs from the five-star price (6.25) to the one-star price (14.61).
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
| Price - closing or last bid | 10.85 |
| Price - 12 month high | 10.95 |
| Price - 12 month low | 10.41 |
| Pricing date | 22 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 0.01 |
| Market capitalization | 208.73 |
| 12 Month High price date | 15 SEP 2026 |
| 12 Month Low price date | 7 JAN 2026 |
| Volume - avg. trading volume for the last 3 months | 0.03 |
| Price - 1 Day % Change | 0.37% |
| Price - 13 week price percent change | 1.21% |
| Price - 26 week price percent change | 1.50% |
| Price - 5 Day % Change | 0.37% |
| Price - 52 week price percent change | 4.03% |
| Price - YTD price percent change | 3.43% |
| Price % Change Month To Date | -0.28% |
| EPS excluding extraordinary items - most recent fiscal year | 0.290 |
| EPS excluding extraordinary items - trailing 12 month | 0.260 |
| EPS Normalized - most recent fiscal year | 0.290 |
| Revenue/share - most recent fiscal year | 0.000 |
| Revenue/share - trailing 12 month | 0.000 |
| Book value per share - most recent fiscal year | 7.993 |
| Book value per share - most recent quarter | 7.747 |
| Book value (tangible) per share - most recent fiscal year | 7.993 |
| Book value (tangible) per share - most recent quarter | 7.747 |
| Cash per share - most recent fiscal year | 0.001 |
| Cash per share - most recent quarter | 0.004 |
| Cash Flow per share - most recent fiscal year | -0.043 |
| Cash Flow per share - trailing 12 month | -0.060 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.000 |
| EBITD per share - trailing 12 month | 0.254 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 0.290 |
| EPS Basic excluding extraordinary items - trailing 12 month | 0.260 |
| EPS including extraordinary items - most recent fiscal year | 0.290 |
| EPS including extraordinary items - trailing 12 month | 0.260 |
| Free Cash Flow per share - trailing 12 month | -0.060 |
| P/E excluding extraordinary items, most recent fiscal year | 41.58 |
| P/E Normalized, most recent fiscal year | 41.58 |
| Price to sales - most recent fiscal year | — |
| Price to Tangible Book - most fiscal year | 1.40 |
| Price to Free Cash Flow per Share - most recent fiscal year | — |
| Price to Cash Flow per share - trailing 12 month | — |
| Price to Book - most recent fiscal year | 1.40 |
| P/E excluding extraordinary items high, trailing 12 months | 87.10 |
| P/E excluding extraordinary items low, trailing 12 months | 36.41 |
| Net Debt, LFI | 1.01 |
| Net Debt, LFY | 0.17 |
| Dividend Yield - 5 Year Average | — |
| Dividend Yield - indicated annual dividend divided by closing price | — |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 0.00% |
| Free Cash Flow - most recent fiscal year | -0.94 |
| LT debt/equity - most recent fiscal year | 0.00% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 0.11% |
| LT debt/equity - most recent quarter | 0.00% |
| Total debt/total equity - most recent quarter | 0.74% |
| Free Cash Flow - trailing 12 month | -1.32 |
| Payout ratio - trailing 12 month | — |
| Revenue - most recent fiscal year | 0.00 |
| Revenue - trailing 12 month | 0.00 |
| EBITD - most recent fiscal year | 6.36 |
| EBITD - trailing 12 month | 5.54 |
| Earnings before taxes - most recent fiscal year | 6.36 |
| Earnings before taxes - trailing 12 month | 5.54 |
| Net Income available to common - most recent fiscal year | 6.36 |
| Net Income available to common - trailing 12 months | 5.54 |
| Earnings before taxes Normalized - most recent fiscal year | 6.36 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 0.26 |
| Net Profit Margin % - 1st historical fiscal year | — |
| Net Profit Margin % - trailing 12 month | — |
| Operating margin - 1st historical fiscal year | — |
| Operating margin - trailing 12 month | — |
| Pretax margin - trailing 12 month | — |
| Pretax margin - 1st historical fiscal year | — |
| Operating Margin - 5 year average | — |
| Pretax Margin - 5 year average | — |
| Free Operating Cash Flow/Revenue, 5 Year Average | — |
| Free Operating Cash Flow/Revenue, TTM | — |
| Net Profit Margin - 5 year average | — |
| Return on average assets - most recent fiscal year | 3.57% |
| Return on average assets - trailing 12 month | 3.14% |
| Return on average equity - most recent fiscal year | 3.70% |
| Return on average equity - trailing 12 month | 3.27% |
| Return on average assets - 5 year average | -53.63% |
| Return on average equity - 5 year average | — |
| Net Income/employee - most recent fiscal year | — |
| Revenue/employee - most recent fiscal year | — |
| Revenue growth rate, 5 year | — |
| EPS growth rate, 5 year | — |
| Growth rate% - dividend, 3 year | — |
| Revenue/share (5 yr growth) | — |
| Growth rate% - Revenue, 3 year | — |
| Growth rate% - EPS, 3 year | — |
| Book value per share growth rate, 5 year | — |
| Capital Spending growth rate, 5 year | — |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | — |
Financial forecast (AUD, millions except per share)
No consensus estimates are available for this company.
Financials (USD, millions)
| Period end: | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months |
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Translational Development Acquisition Corp is a newly organized blank check company.